Dithiolopyrrolone Antibiotics: Biosynthesis, Mode of Action and Cellular Function
Dithiolopyrrolone Antibiotics: Biosynthesis, Mode of Action and Cellular Function
批准号:
8695588
负责人:
Bo Li
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-03-01 至 2016-06-30
关键词:
AccountingAffectAffinityAffinity LabelsAnabolismAnimal ModelAntibioticsAntineoplastic AgentsBacteriaBiochemical PathwayBiochemistryBioinformaticsBiological FactorsBiological ProcessCancer cell lineCell physiologyChemicalsChemistryCommunicable DiseasesCoupledDNADNA-Directed RNA PolymeraseDataDevelopmentDisulfidesEngineeringEnvironmentEnzymatic BiochemistryEnzymesEscherichia coliExhibitsFamilyFlavinsFoundationsFutureGene ClusterGene ExpressionGenesGeneticGenomeHomologous GeneHumanIn VitroIndividualInvestigationLabelLearningLightLogicMalignant NeoplasmsMentorsMethodsMicrobial GeneticsMicrobiologyMiningModelingMolecular TargetNatureOrganismOxidation-ReductionOxidative StressPathway interactionsPharmaceutical PreparationsPharmacologic SubstancePhasePhysiologicalPost-Translational Protein ProcessingProductionProteomicsRNA chemical synthesisRadioRegulationRegulator GenesResearchRoleSignal TransductionSignaling MoleculeStreptomycesStructureStructure-Activity RelationshipSystems BiologyTestingTherapeuticThinkingTrainingWorkaffinity labelinganalogantimicrobialbasebiological adaptation to stressdesignenzyme mechanismexperiencefollow-upfungusgenetic manipulationimprovedin vivoinsightmedical schoolsmembermicroorganismnovelnovel therapeuticsoxidationpromoterresearch studyscaffoldskillssynthetic enzymetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Dithiolopyrrolone antibiotics share a unique disulfide-bridged heterobicyclic core and exhibit
potent activities against bacteria, fungi, and mammalian cancer cell lines. Although the
dithiolopyrrolones have been known for over sixty years, their therapeutic mode of action,
biosynthesis, and physiological functions are not well understood. A genome-mining approach
was used to identify the biosynthetic gene cluster of a particular dithiolopyrrolone compound,
holomycin, in its producing strain, Streptomyces clavuligerus. This preliminary work established
the foundation for more intensive investigations of the dithiolopyrrolone scaffold, described
herein. This proposal includes three specific aims: 1) Elucidating the modes of action of
dithiolopyrrolones including holomycin. Holomycin is hypothesized to exert its activity through
redox cycling and/or protein modification. A systems biology approach will be undertaken to
group holomycin with antibiotics with known mechanisms of action. In conjunction,
transcriptional profiling studies of holomycin-treated bacteria will be carried out to further provide
clues regarding the mode of action. Pull down experiments will also be performed in bacterial
culture to identify the molecular target(s) and chemical reactivity of holomycin; 2) Investigating
the biosynthetic pathway of dithiolopyrrolones. In-depth characterization of the order and
mechanisms of individual enzymatic transformations will be carried out regarding the holomycin
biosynthetic pathway, in particular the redox chemistry involved in the oxidation steps and
bicyclic ring formation. Further, a genome-mining approach will be utilized to uncover unknown
dithiolopyrrolone gene clusters and novel dithiolopyrrolone compounds; 3) Scrutinizing the
functions and regulatory mechanisms of holomycin in Streptomyces. Though identified as
antibiotics and anticancer molecules, dithiolopyrrolones are hypothesized to serve as signaling
molecules for their producing organisms. Transcriptional profiling studies will be undertaken to
examine the effects of holomycin in S. clavuligerus and model Streptomyces strain, S.
coelicolor. The regulatory mechanism of holomycin production will be explored through
transcriptional analysis and genetic manipulation of the regulatory genes present in the cluster.
The studies described in this proposal will significantly advance our understanding of Nature's
logic to assemble dithiolopyrrolones and their mechanisms of action, provide new ways to
convert them into viable therapeutics for cancer and infectious diseases, and shed light on the
intricate regulatory network of secondary metabolites in Streptomyces, the industrial workhorses
accounting for a large number of drugs in current use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic
-
批准号:10830540
-
项目类别:
-
资助金额:$0.73万
-
财政年份:2022
-
负责人:Bo Li
-
依托单位:
Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic
-
批准号:10911758
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2022
-
负责人:Bo Li
-
依托单位:
Bruker D8 VENTURE Diffractometer
-
批准号:10429832
-
项目类别:
-
资助金额:$42.83万
-
财政年份:2022
-
负责人:Bo Li
-
依托单位:
Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic
-
批准号:10707436
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2022
-
负责人:Bo Li
-
依托单位:
Mechanisms of unusual enzymes in the biosynthesis of a copper-containing antibiotic
-
批准号:10567957
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2022
-
负责人:Bo Li
-
依托单位:
Antigen-independent prediction and biomarker identification of cancer-specific T cells
-
批准号:10248560
-
项目类别:
-
资助金额:$37.49万
-
财政年份:2020
-
负责人:Bo Li
-
依托单位:
Antigen-independent prediction and biomarker identification of cancer-specific T cells
-
批准号:10900208
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2020
-
负责人:Bo Li
-
依托单位:
Antigen-independent prediction and biomarker identification of cancer-specific T cells
-
批准号:10413251
-
项目类别:
-
资助金额:$37.52万
-
财政年份:2020
-
负责人:Bo Li
-
依托单位:
Dithiolopyrrolone Antibiotics: Biosynthesis, Mode of Action and Cellular Function
-
批准号:8224560
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:Bo Li
-
依托单位:
Dithiolopyrrolone Antibiotics: Biosynthesis, Mode of Action and Cellular Function
-
批准号:8720018
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2012
-
负责人:Bo Li
-
依托单位:
Level-Set Variational Implicit-Solvent Approach to Biomolecular Interactions
-
批准号:8286989
-
项目类别:
-
资助金额:$28.92万
-
财政年份:2010
-
负责人:Bo Li
-
依托单位:
Level-Set Variational Implicit-Solvent Approach to Biomolecular Interactions
-
批准号:8505503
-
项目类别:
-
资助金额:$28.25万
-
财政年份:2010
-
负责人:Bo Li
-
依托单位:
Level-Set Variational Implicit-Solvent Approach to Biomolecular Interactions
-
批准号:8100526
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2010
-
负责人:Bo Li
-
依托单位:
Level-Set Variational Implicit-Solvent Approach to Biomolecular Interactions
-
批准号:8045568
-
项目类别:
-
资助金额:$29.9万
-
财政年份:2010
-
负责人:Bo Li
-
依托单位:
海外基金